Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Opal

Showing results (31-40 of 168) with videos related to

Pageof 17
Sort By:
Drugs|January 10, 2006
Role of Toll-like receptors in infection and immunity: clinical implicationsPatricia Cristofaro, Steven M Opal
Critical Care Clinics|November 18, 2019
Biomarkers of Infection and SepsisSteven M Opal, Xavier Wittebole
Critical Care (London, England)|August 2, 2006
Coagulation abnormalities in critically ill patientsMarcel Levi, Steven M Opal
Infectious Disease Clinics of North America|February 5, 2017
Severe Pneumonia Caused by Legionella pneumophila: Differential Diagnosis and Therapeutic ConsiderationsAbdullah Chahin, Steven M Opal
JAMA|December 3, 2009
Antibiotic usage and resistance: gaining or losing ground on infections in critically ill patients?Steven M Opal, Thierry Calandra
Critical Care Medicine|January 25, 2003
Endotoxin as a drug targetSteven M Opal, Thomas Glück
Drugs|April 3, 2004
Advances in sepsis therapyThomas Glück, Steven M Opal
Current Opinion in Critical Care|September 13, 2008
Is the mortality rate for septic shock really decreasing?Eirini Christaki, Steven M Opal
Expert Opinion on Therapeutic Targets|September 23, 2003
The Toll-like receptors and their role in septic shockPatricia Cristofaro, Steven M Opal
Critical Care Medicine|December 24, 2008
Translational research in the development of novel sepsis therapeutics: logical deductive reasoning or mission impossible?Steven M Opal, Eleni Patrozou
Pageof 17

Showing results (31-40 of 168) with videos related to

Sort By:
Pageof 17
Drugs|January 10, 2006
Role of Toll-like receptors in infection and immunity: clinical implicationsPatricia Cristofaro, Steven M Opal
Critical Care Clinics|November 18, 2019
Biomarkers of Infection and SepsisSteven M Opal, Xavier Wittebole
Critical Care (London, England)|August 2, 2006
Coagulation abnormalities in critically ill patientsMarcel Levi, Steven M Opal
Infectious Disease Clinics of North America|February 5, 2017
Severe Pneumonia Caused by Legionella pneumophila: Differential Diagnosis and Therapeutic ConsiderationsAbdullah Chahin, Steven M Opal
JAMA|December 3, 2009
Antibiotic usage and resistance: gaining or losing ground on infections in critically ill patients?Steven M Opal, Thierry Calandra
Critical Care Medicine|January 25, 2003
Endotoxin as a drug targetSteven M Opal, Thomas Glück
Drugs|April 3, 2004
Advances in sepsis therapyThomas Glück, Steven M Opal
Current Opinion in Critical Care|September 13, 2008
Is the mortality rate for septic shock really decreasing?Eirini Christaki, Steven M Opal
Expert Opinion on Therapeutic Targets|September 23, 2003
The Toll-like receptors and their role in septic shockPatricia Cristofaro, Steven M Opal
Critical Care Medicine|December 24, 2008
Translational research in the development of novel sepsis therapeutics: logical deductive reasoning or mission impossible?Steven M Opal, Eleni Patrozou
Pageof 17